Results 171 to 180 of about 44,899 (264)

Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles. [PDF]

Clin Transl Sci
Bennett MH, Poweleit EA, Vaughn SE, Retke B, Toren P, Strawn JR, Ramsey LB.   +6 more
europepmc   +1 more source

Analytical Validation of an Annotation Tool for WGS-Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology. [PDF]

Clin Transl Sci
Diekstra MHM, Biesot N, Donders J, Verwiel ETP, Janse A, Huitema ADR, Hanff LM, Tops BBJ, Kemmeren P, Hehir-Kwa JY.   +9 more
europepmc   +1 more source

IDENTIFICATION OF GENES ASSOCIATED WITH QT INTERVAL USING THE 50K CARDIO-METABOLIC SNP CHIP: RESULTS FROM THE WHITEHALL II STUDY

, 2009
Drenos, F, Hingorani, AD, Humphries, SE, Kivamaki, M, Kumari, M, MacFarlane, P, Pallas, J, Palmen, J, Shah, S, Shah, T, Sofat, R, Talmud, PJ, Verzilli, C, Whittaker, J   +13 more
core   +1 more source

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole. [PDF]

Schizophr Bull
Gras C, Piras M, Ranjbar S, Grosu C, Girardin FR, Vandenberghe F, Ansermot N, Grandjean C, Kaiser S, Gamma F, Plessen KJ, von Gunten A, Conus P, Crettol S, Eap CB.   +14 more
europepmc   +1 more source

Impact of CYP2D6 Metabolizer Status on Ondansetron Efficacy in Early Pregnancy Induced Nausea and Vomiting: A Case Control Study. [PDF]

Clin Transl Sci
Liu M, Shuey MM, Holley SE, Fountain DF, Jaworski J, Griffin C, Kim J, Stec M, Sunthankar SD, Ong HH, Gangireddy S, Wei WQ, Gaedigk A, Velez Edwards DR, Kawai VK.   +14 more
europepmc   +1 more source

PBPK modeling of the antidepressant doxepin incorporating CYP2D6 genotype for precision pharmacotherapy. [PDF]

Arch Pharm Res
Seok J, Kang N, Lee JJ, Cho CK, Lee YJ.
europepmc   +1 more source

Longitudinal Management of Post-traumatic Brain Injury Bipolar-Spectrum Disorder With Low-Dose Oral Glutamatergic Augmentation: Extended Follow-Up Revealing Induction, Overshoot, Stabilization, and Transition to PRN Maintenance. [PDF]

Cureus
Cheung N.
europepmc   +1 more source

Psychiatric pharmacogenomics: from genetic evidence to clinical integration - structural, educational, and ethical challenges. [PDF]

Front Pharmacol
Mangalagiu AG, Petrescu BM, Riga S, Vasiliu O.   +3 more
europepmc   +1 more source

Pharmacogenetic Variability and Quality of Life in Adolescent Patients with Schizophrenia: The Impact of Metabolizer Status, Symptom Severity, and Adverse Reactions to Antipsychotic Treatment. [PDF]

J Clin Med
Bucatos BO, Romosan AM, Dehelean L, Romosan RȘ, Cojocaru A, Kundnani NR, Sharma A, Berceanu Vaduva DM, Nussbaum LA.   +8 more
europepmc   +1 more source

DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs. [PDF]

Front Psychiatry
Cheung N.
europepmc   +1 more source